Synageva BioPharma (GEVA) Files $150M Mixed Shelf

Synageva BioPharma Corp. (Nasdaq: GEVA) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $150 million of Common Stock, Preferred Stock, Warrants, Debt Securities, or any combination thereof.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tempest Therapeutics raises $2.5M in private placement
• FDA approves Scholar Rock's ISEMBYLD for spinal muscular atrophy
• Amrize names Mario Gross as Building Envelope president